Garenoxacin
目录号: A16856
Garenoxacin(T-3811ME,BMS-284756)是一种新型的des-F(6) quinolone,已被证明在体外对包括革兰氏阳性菌和革兰氏阴性菌以及厌氧菌在内的广泛临床重要病原体具有有效性。
| Discription | Garenoxacin (T-3811ME, BMS-284756) is a novel des-F(6) quinolone that has been shown to be effective in vitro against a wide range of clinically important pathogens, including gram-positive and gram-negative aerobes and anaerobes. | ||
|---|---|---|---|
| Targets |
|
| 目录号 | A16856 |
|---|---|
| 分子式 | C23H20F2N2O4 |
| 分子量 | 426.41 |
| CAS号 | 194804-75-6 |
| SMILES | O=C(C1=CN(C2CC2)C3=C(C=CC(C4=CC5=C([C@@H](C)NC5)C=C4)=C3OC(F)F)C1=O)O |
| 其他名称 | T-3811ME, BMS-284756, T3811ME, BMS284756, T 3811ME, BMS 284756 |
| 储存条件 | Store lyophilized at -20ºC, keep desiccated. |
| In vitro | DMSO | 2 mg/mL (4.69 mM) | |
| Water | Insoluble | ||
| Ethanol | Insoluble | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 23.45 mL | 117.26 mL | 234.52 mL |
| 0.5 mM | 4.69 mL | 23.45 mL | 46.9 mL |
| 1 mM | 2.35 mL | 11.73 mL | 23.45 mL |
| 5 mM | 0.47 mL | 2.35 mL | 4.69 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2